CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE ACETATE
✉ Email this page to a colleague
All Clinical Trials for methylprednisolone acetate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00185692 ↗ | Allogeneic Transplantation From Related Haploidentical Donors | Completed | Stanford University | Phase 2 | 2000-08-01 | The purpose of the study is to evaluate the feasibility and safety of transplanting CD34+ selected hematopoietic cells from a haploidentical related donor following a nonmyeloablative regimen of total lymphoid irradiation (TLI) and antithymocyte globulin (ATG). |
| NCT00290589 ↗ | A Trial of Corticosteroids for Low Back Pain | Completed | Montefiore Medical Center | Phase 3 | 2003-06-01 | Low back pain is a common symptom that functionally disables many people. When the low back pain is accompanied by pain that shoots down the leg, it is felt to be caused by a herniated disc. We are conducting this study to determine if a powerful anti-inflammatory agent will decrease the pain and functional impairment that is associated with this illness. |
| NCT00492973 ↗ | Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results? | Completed | St. Joseph's Health Care London | N/A | 2006-03-01 | Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement. |
| NCT00492973 ↗ | Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results? | Completed | New Lexington Clinic | N/A | 2006-03-01 | Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement. |
| NCT01037907 ↗ | A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) | Terminated | BTG International Inc. | Phase 2 | 2009-11-01 | To determine the efficacy and safety of an oral drug (BGC20-0134) in patients with relapsing remitting multiple sclerosis. Specifically, the cumulative number of new gadolinium enhancing lesions after 24 weeks of treatment with BGC20-0134. |
| NCT01132677 ↗ | A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis | Unknown status | LifeMark Health | N/A | 2010-05-01 | Do differences exist between patients who receive a single intra-articular injection of corticosteroid versus patients who receive a single intra-articular injection of hyaluronic acid for the treatment of knee osteoarthritis at 1, 3 and 6 weeks, and 3 and 6 months post injection? |
| NCT01144143 ↗ | Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab | Completed | Centocor, Inc. | Phase 4 | 2007-07-01 | The purpose of this study is to determine if an anti-inflammatory drug, called infliximab, will reduce inflammation in the synovial lining in patients with an early stage of osteoarthritis of the knee. It will also help determine if the study medication decreases the accumulation of synovial fluid and prevents cartilage breakdown. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for methylprednisolone acetate
Condition Name
Clinical Trial Locations for methylprednisolone acetate
Trials by Country
Clinical Trial Progress for methylprednisolone acetate
Clinical Trial Phase
Clinical Trial Sponsors for methylprednisolone acetate
Sponsor Name
